Deutsche Bank
IMNP

Deutsche Bank’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Deutsche Bank’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4
Closed – – 5770
2017
Q4 		$0 Hold
4
– – ﹤0.01% 5273
2017
Q3 		$0 Sell
4
-2,100
-100% -$3.67K ﹤0.01% 5242
2017
Q2 		$6K Buy
2,104
+2,103
+210,300% +$5.65K ﹤0.01% 4735
2017
Q1 		$0 Hold
1
– – ﹤0.01% 5239
2016
Q4 		$0 Hold
1
– – ﹤0.01% 5192
2016
Q3 		$0 Hold
1
– – ﹤0.01% 5399
2016
Q2 		$0 Buy
+1
New +$8 ﹤0.01% 5462
2015
Q1 		– Sell
-1,123
Closed -$42K – 6275
2014
Q4 		$42K Hold
1,123
– – ﹤0.01% 5220
2014
Q3 		$75K Buy
+1,123
New +$80K ﹤0.01% 4652

Other funds holding IMNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's IMNP Position: Q1 2018 in Review

Deutsche Bank sold out of Immune Pharmaceuticals Inc. (IMNP) in Q1 2018, closing a stake of 4 shares.

Deutsche Bank first reported a position in IMNP in Q3 2014 and held it in 9 quarters. The position peaked at $75K in Q3 2014. 17 funds tracked by Wall St. Rank hold IMNP as of Q1 2018.

  • Deutsche Bank reported no remaining Immune Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 4 Immune Pharmaceuticals Inc. shares in Q1 2018.
  • Deutsche Bank first reported a position in Immune Pharmaceuticals Inc. in Q3 2014 and held it in 9 quarters.
  • Deutsche Bank's Immune Pharmaceuticals Inc. position peaked at $75K in Q3 2014.
  • 17 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.